4D Molecular Therapeutics Statistics
NASDAQ: FDMTHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
12.70+0.11 (+0.87%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
4D Molecular Therapeutics by the numbers
4D Molecular Therapeutics has a market capitalization of $701.6 million based on 55.24M shares outstanding. With trailing EPS of $-2.63, 4D Molecular Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 6.8% below its 50-day average and 20.9% above its 200-day average.
Average daily trading volume is 926.78K shares, or about $11.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
FDMT valuation vs. peer median
| Metric | FDMT | Peer median | Difference |
|---|---|---|---|
| Market cap | $701.60M | $655.99M | +7% |
| Avg. volume | 926.78K | 1.00M | -8% |
Peer median across 8 companies: AURA, PROK, SLDB, PRME, DBVT, ETRA, SANA, VALN.
Valuation
- Market cap
- $701.60M
- EPS (TTM)
- $-2.63
- Shares outstanding
- 55.24M
Price and trading
- Previous close
- 12.59
- Open
- 12.42
- Day range
- 12.12 – 12.74
- 52-week range
- 6.96 – 16.93
- 52-week change
- +31.47%
- Beta
- —
- Volume
- 970.76K
- Average volume
- 926.78K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 10, 2026
Additional statistics
- Market Cap
- 701.60M
- Forward Pe
- -3.10
- Eps
- -2.63
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 16.93
- Week52 Low
- 6.96
- Avg Volume
- 926.78K
- Shares Outstanding
- 55.24M
- Ma50
- 13.62
- Ma200
- 10.51
- Earnings Date
- Nov 10, 2026
- Pct From52w High
- -24.99%
- Pct From52w Low
- 82.47%